Squarepoint’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,793
Closed -$46K 4291
2025
Q3
$46K Sell
22,793
-421
-2% -$771 ﹤0.01% 4238
2025
Q2
$41.8K Buy
+23,214
New +$44.7K ﹤0.01% 4331
2025
Q1
Sell
-69,598
Closed -$237K 4611
2024
Q4
$270K Buy
+69,598
New +$555K ﹤0.01% 4235
2024
Q3
Sell
-52,628
Closed -$342K 4129
2024
Q2
$237K Buy
+52,628
New +$535K ﹤0.01% 3563
2024
Q1
Sell
-110,377
Closed -$1.6M 4049
2023
Q4
$1.6M Buy
110,377
+66,316
+151% +$806K ﹤0.01% 2162
2023
Q3
$606K Buy
+44,061
New +$795K ﹤0.01% 2648

Other funds holding BMEA

Squarepoint's BMEA Position: Q4 2025 in Review

Squarepoint sold out of Biomea Fusion (BMEA) in Q4 2025, closing a stake of 22,793 shares — an estimated $46K sold.

Squarepoint first reported a position in BMEA in Q3 2023 and held it in 6 quarters. The position peaked at $1.6M in Q4 2023. 60 funds tracked by Wall St. Rank hold BMEA as of Q4 2025.

  • Squarepoint reported no remaining Biomea Fusion position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 22,793 Biomea Fusion shares in Q4 2025, an estimated $46K.
  • Squarepoint first reported a position in Biomea Fusion in Q3 2023 and held it in 6 quarters.
  • Squarepoint's Biomea Fusion position peaked at $1.6M in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.